Pharmacia and Upjohn

Acknowledgments. We thank the NIH and NSF for their support of our program. We acknowledge the many talented coworkers that have contributed to the design and execution of this research program their work is cited in the references. C. J. S. is grateful to the Department of Education and Pharmacia and Upjohn for fellowship support. We thank Alex Buckmelter and Claudia Roberson for helpful comments on this manuscript. 

Pharmacia and Upjohn. Edronax. In ABPI compendium of data sheets and summaries of product characteristics 1998-99. London Datapharm Publications, 1998 997-998. 

Frisch H. Pharmacovigilance the use of KIGS (Pharmacia and Upjohn International Growth Database) to monitor... 

Price DA, Wilton P, Jonsson P, Albertsson-Wikland K, Chatelain P, Cutfield W, Ranke MB. Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996. Horm Res 1998 49(2) 91-7. 

Brumfield JC. The Pharmacia and Upjohn experience in selecting a photostability guideline option. 3rd Int. Conf. Photostab. Drug Subst. Prod., Washington DC, July 10 14, 1999. 

Both Celebrex and Bextra were developed by Searle, which was subsequently purchased by Monsanto. Monsanto later merged with Pharmacia and Upjohn, and the resultant company later merged with Pfizer. 23 University of Rochester v. G.D. Searle Co., 249 F.2d 216 (W.D. N.Y. 2003). The District Court also held the claims to be invalid due to lack of enablement, an issue we will discuss further later in this chapter. 

ZYF Pharm Chemical Sanofi-Synthelabo Sanofi Aventis Bayer Pharma Pharmacia and Upjohn... 

Pharmacia and Upjohn Pharmacia and Upjohn Ranbaxy Global Consumer Healthcare... 

Gage J.R., Cabaj J.E. US Patent No. 5,922,914 July 13, 1999 Assigned Pharmacia and Upjohn Company, Kalamazoo, Mich. 

---